Dose verification of volumetric-modulated arc therapy using one-dimensional and two-dimensional dosimeters
- 19 November 2018
- journal article
- research article
- Published by Cambridge University Press (CUP) in Journal of Radiotherapy in Practice
- Vol. 18 (03) , 304-308
Abstract
PurposeTo verify dose delivery and quality assurance of volumetric-modulated arc therapy (VMAT) for head and neck (H&N) cancer.MethodThe Imaging and Radiation Oncology Core Houston (IROC-H) H&N phantom with thermoluminescent dosimeters (TLDs) and films, were imaged with computed tomography scan and the reconstructed image was transferred to pinnacle treatment planning system (TPS). On TPS, the planning target volume (PTV), secondary target volume (STV) and organ at risk (OAR) were delineated manually and a treatment plan was made. The dose constraints were determined for the concerned organs according to IROC-H prescription. The treatment plan was optimised using adoptive convolution algorithm to improve dose homogeneity and conformity. The dose calculation was performed using C.C Convolution algorithm and a Varian True Beam linear accelerator was used to deliver the treatment plan to the H&N phantom. The delivered radiation dose to the phantom was measured through TLDs and GafChromic external beam radiotherapy 2 (EBT2) films. The dosimetric performance of the VMAT delivery was studied by analysing percent dose difference, isodose line profile and gamma analysis of the TPS-computed dose and linac-delivered doses.ResultThe percent dose difference of 3.8% was observed between the planned and measured doses of TLDs and a 1.5-mm distance to agreement (DTA) was observed by comparing isodose line profiles. Passed the gamma criteria of 3%/3 mm was with good percentages.ConclusionThe dosimetric performance of VMAT delivery for a challenging H&N radiotherapy can be verified using TLDs and films embedded in an anthropomorphic H&N phantom.Keywords
All Related Versions
This publication has 20 references indexed in Scilit:
- American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) Practice Guideline for Intensity-modulated Radiation Therapy (IMRT)American Journal of Clinical Oncology, 2012
- Volumetric-modulated Arc Therapy in Head and Neck Radiotherapy: A Planning Comparison using Simultaneous Integrated Boost for Nasopharynx and Oropharynx CarcinomaClinical Oncology, 2011
- Investigation of the Compounding Effect of MLC Positioning Uncertainty and Gantry Angular Acceleration in VMAT DeliveryInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trialThe Lancet Oncology, 2011
- Stereotactic radiotherapy for peripheral lung tumors: A comparison of volumetric modulated arc therapy with 3 other delivery techniquesRadiotherapy and Oncology, 2010
- Volumetric Modulated Arc Therapy: Planning and Evaluation for Prostate Cancer CasesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Volumetric Intensity-Modulated Arc Therapy Vs. Conventional IMRT in Head-and-Neck Cancer: A Comparative Planning and Dosimetric StudyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- DOSE TO NORMAL TISSUES OUTSIDE THE RADIATION THERAPY PATIENT’S TREATED VOLUME: A REVIEW OF DIFFERENT RADIATION THERAPY TECHNIQUESHealth Physics, 2008
- Commissioning and Quality Assurance of RapidArc Radiotherapy Delivery SystemInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- The Effect of Intensity-Modulated Radiotherapy on Radiation-Induced Second MalignanciesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008